NGS-Based Proteomic Services
Powered by Illumina® Protein Prep
Unlock the Power of High-Throughput Proteomics
Our proteomic services deliver deep, actionable insights into human biology—powered by the cutting-edge Illumina® Protein Prep solution with sequencing on the NovaSeq™ X Plus system. Whether you're working in translational
research, biomarker discovery, or multiomics integration, our platform enables
high-sensitivity detection of over 9,500 unique proteins from plasma or
serum samples, all with exceptional speed and reproducibility.
Why Choose Our Proteomic Services?
9,500 Unique Human Proteins in a Single Sample
Explore the proteome with exceptional depth using the SomaScan® assay combined with next-generation sequencing (NGS). Our current assay covers more than 9,500 proteins.
Rapid Turnaround Time
Go from sample to results in less than 2.5 days, with only ~4 hours of hands-on time thanks to fully automated workflows.
Unparalleled Sensitivity and Specificity
Utilizing SOMAmer® reagents, our platform detects proteins at femtomolar sensitivity and shows superior specificity compared to traditional antibody-based methods.
Scalable and Reproducible
Our proteomic services are built for high-throughput studies. Full automation ensures reproducibility across batches, sites, and study designs.
Integrated Data Analysis
We provide data processing through Illumina’s DRAGEN™ Protein Quantification and Illumina Connected Multiomics (ICM), delivering clean, interpretable results ready for downstream discovery.
Applications of NGS-Based Proteomics
• Biomarker Discovery & Validation
Identify novel protein signatures with high specificity across disease states.
• Clinical and Translational Research
Analyze the real-time phenotype of your samples and uncover hidden mechanisms of disease.
• Multiomics Integration
Seamlessly combine proteomic data with genomics and transcriptomics for a full systems biology perspective.
• Immune, Inflammatory, and Cardiometabolic Profiling
Explore complex biological processes across more than 200 validated pathways.
• Longitudinal Cohort Studies
Track changes in protein expression over time, enabling better prediction and monitoring of disease progression.
